TNDM Maintained by Citigroup -- Price Target Lowered to $20

gurufocus.com · 2026-09-30

On October 03, 2023, Citigroup maintained a Neutral rating on Tandem Diabetes Care (TNDM) while adjusting its price target down from $24.00 to $20.00, indicatin

Read the full story at gurufocus.com →